These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 35913830

  • 1. Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer.
    Brachet S, Meillat H, Chanez B, Ratone JP, Brunelle S, Tyran M, Poizat F, de Chaisemartin C, Lelong B.
    Dis Colon Rectum; 2022 Dec 01; 65(12):1464-1474. PubMed ID: 35913830
    [Abstract] [Full Text] [Related]

  • 2. Low Anterior Resection Syndrome After Transanal Total Mesorectal Excision: A Comparison With the Conventional Top-to-Bottom Approach.
    Foo CC, Kin Ng K, Tsang JS, Siu-Hung Lo O, Wei R, Yip J, Lun Law W.
    Dis Colon Rectum; 2020 Apr 01; 63(4):497-503. PubMed ID: 32015290
    [Abstract] [Full Text] [Related]

  • 3. Functional Outcomes and Quality of Life After Transanal Total Mesorectal Excision for Rectal Cancer: A Prospective Observational Study.
    de Lacy FB, Turrado-Rodriguez V, Torroella A, van Laarhoven J, Otero-Piñeiro A, Almenara R, Lacima G, Castells A, Lacy AM.
    Dis Colon Rectum; 2022 Jan 01; 65(1):46-54. PubMed ID: 34596984
    [Abstract] [Full Text] [Related]

  • 4. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
    Benlice C, Koc MA, Gulcu B, Bilgin IA, Akyol C, Baca B, Ozturk E, Guney Y, Utkan G, Er O, Agaoglu F, Yildirim I, Avci N, Elhan AH, Kuzu MA.
    Dis Colon Rectum; 2023 May 01; 66(5):681-690. PubMed ID: 36856669
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quality of Life and Functional Outcomes After Intersphincteric Resection for Ultralow Rectal Cancer: A Prospective Observational Study.
    Zhang B, Zhuo GZ, Zhao Y, Zhao YJ, Zhu J, Liu FF, Ding JH.
    Dis Colon Rectum; 2023 Jul 01; 66(7):1029-1038. PubMed ID: 36602458
    [Abstract] [Full Text] [Related]

  • 7. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
    Meyer VM, Meuzelaar RR, Schoenaker IJH, de Groot JB, Reerink O, de Vos Tot Nederveen Cappel WH, Beets GL, van Westreenen HL.
    Dis Colon Rectum; 2023 May 01; 66(5):671-680. PubMed ID: 34856587
    [Abstract] [Full Text] [Related]

  • 8. Transanal Total Mesorectal Excision in Mid-Low Rectal Cancer: Evaluation of the Learning Curve and Comparison of Short-term Results With Standard Laparoscopic Total Mesorectal Excision.
    Zeng Z, Liu Z, Huang L, Liu H, Jie H, Luo S, Zhang X, Kang L.
    Dis Colon Rectum; 2021 Apr 01; 64(4):380-388. PubMed ID: 33394779
    [Abstract] [Full Text] [Related]

  • 9. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G, Pafundi DP, Sionne F, Pietricola G, D'Agostino L, Gambacorta MA, Valentini V, Coco C.
    Dis Colon Rectum; 2022 Nov 01; 65(11):1306-1315. PubMed ID: 35067503
    [Abstract] [Full Text] [Related]

  • 10. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
    Garoufalia Z, Freund MR, Gefen R, Meyer R, DaSilva G, Weiss EG, Wexner SD.
    Dis Colon Rectum; 2023 Jul 01; 66(7):898-904. PubMed ID: 36649177
    [Abstract] [Full Text] [Related]

  • 11. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
    Xu Z, Valente MA, Sklow B, Liska D, Gorgun E, Kessler H, Rosen DR, Steele SR.
    Dis Colon Rectum; 2023 Jul 01; 66(7):1022-1028. PubMed ID: 36538720
    [Abstract] [Full Text] [Related]

  • 12. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM, Quezada-Diaz F, Hameed I, Kalabin A, Patil S, Smith JJ, Garcia-Aguilar J.
    Dis Colon Rectum; 2021 Dec 01; 64(12):1463-1470. PubMed ID: 34508014
    [Abstract] [Full Text] [Related]

  • 13. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y, Steffens D, Koh CE, Young JM, Solomon MJ.
    Dis Colon Rectum; 2022 Dec 01; 65(12):1475-1482. PubMed ID: 35913831
    [Abstract] [Full Text] [Related]

  • 14. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J, Li J, Huang M, Xie X, Cai Y, Hu H, Ling J, Wu Z, Deng Y.
    Dis Colon Rectum; 2023 Jul 01; 66(7):934-945. PubMed ID: 35834598
    [Abstract] [Full Text] [Related]

  • 15. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK, Park SS, Park SC, Park B, Kim MJ, Sohn DK, Chang HJ, Oh JH.
    Dis Colon Rectum; 2020 Nov 01; 63(11):1500-1510. PubMed ID: 33044291
    [Abstract] [Full Text] [Related]

  • 16. Anterior Resection Syndrome and Quality of Life With Long-term Follow-up After Rectal Cancer Resection.
    Dilke SM, Hadjittofi C, Than M, Tozer PJ, Stearns AT, EQuLAR Study Group.
    Dis Colon Rectum; 2022 Oct 01; 65(10):1251-1263. PubMed ID: 34840295
    [Abstract] [Full Text] [Related]

  • 17. Functional Outcomes and Quality of Life after Redo Anastomosis in Patients With Rectal Cancer: An International Multicenter Comparative Cohort Study.
    Westerduin E, Elfeki H, Frontali A, Lakkis Z, Laurberg S, Tanis PJ, Wolthuis AM, Panis Y, D'Hoore A, Bemelman WA, Juul T.
    Dis Colon Rectum; 2021 Jul 01; 64(7):822-832. PubMed ID: 33902088
    [Abstract] [Full Text] [Related]

  • 18. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
    Maykel JA, Hahn SJ, Beauharnais CC, Meyer DC, Hill SS, Sturrock PR, Davids JS, Alavi K.
    Dis Colon Rectum; 2022 Jun 01; 65(6):827-836. PubMed ID: 34629431
    [Abstract] [Full Text] [Related]

  • 19. Robot-Assisted Total Mesorectal Excision Versus Laparoscopic Total Mesorectal Excision: A Retrospective Propensity Score-Matched Cohort Analysis in Experienced Centers.
    Burghgraef TA, Crolla RMPH, Verheijen PM, Fahim M, van Geloven A, Leijtens JWA, Pronk A, Smits AB, Verdaasdonk EGG, Consten ECJ.
    Dis Colon Rectum; 2022 Feb 01; 65(2):218-227. PubMed ID: 34459449
    [Abstract] [Full Text] [Related]

  • 20. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
    Park SY, Lee SM, Park JS, Kim HJ, Choi GS.
    Dis Colon Rectum; 2021 Jul 01; 64(7):812-821. PubMed ID: 33833141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.